Tovar-Huamani J, et al. - Researchers conducted this PUBA study examining the efficacy of fractional CO₂ laser in the treatment of genitourinary syndrome of menopause (GSM). They assessed GSM symptoms in 60 women (median, interquartile range: 55, 49–69) before, 1 month after the first session and 1 month after the third session of laser (3 sessions with a 30 days interval between them). In addition to improvement in GSM symptoms (vaginal dryness, vaginal itching, vaginal burning, dyspaurenia, dysuria, urinary urgency) following three sessions of fractional CO₂ laser treatment, they noted an improvement in Vaginal Health Index, Frost Index, USMEX and Female Sexual Function Index. Data thereby support the efficacy of fractionated CO₂ laser as an alternative for GSM treatment with positive outcomes that persists over time.